Clinical Trial Update: RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial RESOLVE is evaluating abemaciclib plus letrozole, with optional metformin, zotatifin, or gedatolisib, in endometrial cancer and low-grade serous o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Low-grade Serous Ovarian Cancer
• Ovarian Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)
• Gedatolisib (gedatolisib)
• Letrozole (letrozole)
• Zotatifin (zotatifin)
• metformin (metformin)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Endometrial Cancer, Ovarian Cancer | Phase 2 | Status: RECRUITING